Standout Papers

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myelo... 2010 2026 2015 2020 657
  1. Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib (2010)
    David Marín, Alexandra Bazeos et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
2 intermediate papers

Works of Marco Bua being referenced

Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
2008
European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor
2008
and 2 more

Author Peers

Author Last Decade Papers Cites
Marco Bua 2235 1983 1239 30 2.6k
Jamshid S. Khorashad 2357 2026 1186 67 2.8k
Hugues de Lavallade 2520 1762 1021 80 3.2k
Alistair Reid 2787 2376 1413 69 3.5k
David Marín 3251 2603 1587 112 3.9k
Fausto Castagnetti 2285 1906 1209 105 2.7k
Katy Rezvani 1385 760 302 71 2.5k
Gareth Gerrard 1308 959 468 74 2.1k
Tamás Koncz 1090 607 1972 22 2.6k
P. J. S. M. Kerstens 1330 788 3346 68 3.9k
D. van Zeben 1344 676 3282 41 3.8k

All Works

Loading papers...

Rankless by CCL
2026